You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 11, 2025

Drug Price Trends for NDC 62559-0306


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 62559-0306

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
LIPOFEN 150MG CAP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 62559-0306-90 90 513.32 5.70356 2022-07-15 - 2027-07-14 Big4
LIPOFEN 150MG CAP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 62559-0306-90 90 771.30 8.57000 2022-07-15 - 2027-07-14 FSS
LIPOFEN 150MG CAP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 62559-0306-90 90 532.20 5.91333 2023-01-01 - 2027-07-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Drug NDC: 62559-0306 (Lipofen)

Overview of Lipofen

Lipofen, with the NDC code 62559-0306, is a medication manufactured by ANI Pharmaceuticals, Inc. It is used to manage high cholesterol and triglyceride levels, falling under the category of fibric acid derivatives.

Current Market Trends

Drug Price Increases

The pharmaceutical industry has seen significant price increases in recent years. According to a report by the Assistant Secretary for Planning and Evaluation (ASPE), most prescription drug price increases occur in January and July each year. In January 2022, the average price increase was nearly $150 per drug, representing a 10% increase[2].

Specialty Pharmaceuticals

The market is also influenced by the growth of specialty pharmaceuticals, which include drugs for complex or chronic conditions. Vizient projects a 3.8% drug price inflation driven largely by specialty pharmaceuticals, including weight loss drugs and gene therapies. This trend suggests that prices for many medications, including those like Lipofen, could see increases due to broader market dynamics[4].

Price Projections for Lipofen

Historical Context

To project future price changes for Lipofen, it is essential to consider historical trends. While specific data on Lipofen's price changes is not provided, the general trend in the pharmaceutical industry indicates frequent price increases, particularly in January and July.

Average Price Increases

Given the average price increase of $150 per drug in January 2022 and $250 in July 2022, it is plausible that Lipofen could experience similar percentage increases. However, the actual dollar amount would depend on its current pricing and market position[2].

Specialty and Chronic Condition Medications

Since Lipofen is used for managing cholesterol and triglyceride levels, it falls under the category of chronic condition medications. These types of medications often see price increases due to their essential nature and the ongoing demand. Vizient's projection of a 3.8% overall drug price inflation could be a benchmark for Lipofen's potential price increase[4].

Factors Influencing Price Projections

Inflation and Economic Conditions

The Consumer Price Index (CPI-U) increased by 8.5% between July 2021 and July 2022, which can influence drug price increases. Any price increase for Lipofen would likely need to account for general inflation rates[2].

Regulatory and Market Dynamics

Regulatory changes, competition from generics or biosimilars, and shifts in market demand can also impact pricing. For example, if a generic version of Lipofen is introduced, it could lead to price reductions. However, as of now, there is no indication of such a development for this specific NDC code[1].

Technological and Data Trends

The increasing use of artificial intelligence (AI) and external data in pharmaceutical companies might influence pricing strategies. However, this is more likely to affect the development and marketing of new drugs rather than the pricing of existing ones like Lipofen[3].

Key Takeaways

  • Historical Price Increases: Lipofen, like many other prescription drugs, is likely to experience price increases, particularly in January and July.
  • Market Trends: The overall pharmaceutical market is projected to see a 3.8% price inflation, driven by specialty pharmaceuticals.
  • Inflation Impact: General inflation rates, such as the 8.5% increase in CPI-U between July 2021 and July 2022, can influence drug price increases.
  • Regulatory and Market Factors: Changes in regulatory policies, competition from generics, and market demand shifts can impact pricing.

FAQs

Q: What is the current trend in prescription drug price increases? A: Most prescription drug price increases occur in January and July, with the average price increase in January 2022 being nearly $150 per drug (10% increase)[2].

Q: How does the growth of specialty pharmaceuticals affect drug prices? A: The growth of specialty pharmaceuticals, including weight loss drugs and gene therapies, is projected to drive a 3.8% drug price inflation[4].

Q: What role does inflation play in drug price increases? A: Inflation, such as the 8.5% increase in CPI-U between July 2021 and July 2022, can influence drug price increases, with some increases exceeding general inflation rates[2].

Q: How might AI and data trends impact the pricing of drugs like Lipofen? A: While AI and data trends are more likely to affect the development and marketing of new drugs, they may indirectly influence pricing strategies by optimizing operational costs and improving market analysis[3].

Q: Are there any specific regulatory factors that could impact the price of Lipofen? A: Regulatory changes, such as the introduction of generic versions or changes in FDA approvals, could impact the pricing of Lipofen. However, as of now, there are no such indications for this specific NDC code[1].

Sources

  1. ANI Pharmaceuticals, Inc. - List of Drugs - NDC Labeler/Manufacturer - FindACode
  2. Price Increases for Prescription Drugs, 2016-2022 - ASPE
  3. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch - Intelligencia.ai
  4. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient Inc.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.